A citation-based method for searching scientific literature

Amy L Gross, William J Blot, Kala Visvanathan. JAMA 2018
Times Cited: 10







List of co-cited articles
48 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.
Christopher P Childers, Kimberly K Childers, Melinda Maggard-Gibbons, James Macinko. J Clin Oncol 2017
130
60

Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award.
Mary-Claire King, Ephrat Levy-Lahad, Amnon Lahad. JAMA 2014
172
40

Family communication of BRCA1/2 results and family uptake of BRCA1/2 testing in a diverse population of BRCA1/2 carriers.
Julia Fehniger, Feng Lin, Mary S Beattie, Galen Joseph, Celia Kaplan. J Genet Couns 2013
43
40

Inherited Mutations in Women With Ovarian Carcinoma.
Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger,[...]. JAMA Oncol 2016
335
30

Disparities in genetics assessment for women with ovarian cancer: Can we do better?
Erica Manrriquez, Jocelyn S Chapman, Julie Mak, Amie M Blanco, Lee-May Chen. Gynecol Oncol 2018
22
30

Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities.
Larissa A Meyer, Meaghan E Anderson, Robin A Lacour, Anuj Suri, Molly S Daniels, Diana L Urbauer, Graciela M Nogueras-Gonzalez, Kathleen M Schmeler, David M Gershenson, Karen H Lu. Obstet Gynecol 2010
80
30

Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women.
Ranjit Manchanda, Shreeya Patel, Vladimir S Gordeev, Antonis C Antoniou, Shantel Smith, Andrew Lee, John L Hopper, Robert J MacInnis, Clare Turnbull, Susan J Ramus,[...]. J Natl Cancer Inst 2018
73
30

Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer.
Anne Marie McCarthy, Mirar Bristol, Susan M Domchek, Peter W Groeneveld, Younji Kim, U Nkiru Motanya, Judy A Shea, Katrina Armstrong. J Clin Oncol 2016
73
30

Uptake of genetic testing by relatives of lynch syndrome probands: a systematic review.
Ravi N Sharaf, Parvathi Myer, Christopher D Stave, Lisa C Diamond, Uri Ladabaum. Clin Gastroenterol Hepatol 2013
78
30

Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk.
Jennifer L Caswell-Jin, Tanya Gupta, Evan Hall, Iva M Petrovchich, Meredith A Mills, Kerry E Kingham, Rachel Koff, Nicolette M Chun, Peter Levonian, Alexandra P Lebensohn,[...]. Genet Med 2018
54
30

Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.
Allison W Kurian, Kevin C Ward, Ann S Hamilton, Dennis M Deapen, Paul Abrahamse, Irina Bondarenko, Yun Li, Sarah T Hawley, Monica Morrow, Reshma Jagsi,[...]. JAMA Oncol 2018
67
30

Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients.
Allison W Kurian, Kevin C Ward, Nadia Howlader, Dennis Deapen, Ann S Hamilton, Angela Mariotto, Daniel Miller, Lynne S Penberthy, Steven J Katz. J Clin Oncol 2019
90
30

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.
Amy P M Finch, Jan Lubinski, Pål Møller, Christian F Singer, Beth Karlan, Leigha Senter, Barry Rosen, Lovise Maehle, Parviz Ghadirian, Cezary Cybulski,[...]. J Clin Oncol 2014
328
20

Breast-cancer risk in families with mutations in PALB2.
Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, Daniel Barrowdale, Katri Pylkäs, Jonathan Roberts, Andrew Lee, Deepak Subramanian, Kim De Leeneer, Florentia Fostira,[...]. N Engl J Med 2014
472
20

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
783
20

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Ian J Jacobs, Usha Menon, Andy Ryan, Aleksandra Gentry-Maharaj, Matthew Burnell, Jatinderpal K Kalsi, Nazar N Amso, Sophia Apostolidou, Elizabeth Benjamin, Derek Cruickshank,[...]. Lancet 2016
465
20

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.
Mansoor R Mirza, Bradley J Monk, Jørn Herrstedt, Amit M Oza, Sven Mahner, Andrés Redondo, Michel Fabbro, Jonathan A Ledermann, Domenica Lorusso, Ignace Vergote,[...]. N Engl J Med 2016
968
20

Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.
Saundra S Buys, Edward Partridge, Amanda Black, Christine C Johnson, Lois Lamerato, Claudine Isaacs, Douglas J Reding, Robert T Greenlee, Lance A Yokochi, Bruce Kessel,[...]. JAMA 2011
706
20

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
Kathleen Moore, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael Friedlander, Alla Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S Sonke,[...]. N Engl J Med 2018
717
20

Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations.
Esme Finlay, Jill E Stopfer, Eric Burlingame, Katherine Goldfeder Evans, Katherine L Nathanson, Barbara L Weber, Katrina Armstrong, Timothy R Rebbeck, Susan M Domchek. Genet Test 2008
98
20

Evaluating the utilization of educational materials in communicating about Lynch syndrome to at-risk relatives.
Kristen Dilzell, Kerry Kingham, Kelly Ormond, Uri Ladabaum. Fam Cancer 2014
22
20

Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
Marc D Schwartz, Heiddis B Valdimarsdottir, Beth N Peshkin, Jeanne Mandelblatt, Rachel Nusbaum, An-Tsun Huang, Yaojen Chang, Kristi Graves, Claudine Isaacs, Marie Wood,[...]. J Clin Oncol 2014
148
20

Communication of BRCA results and family testing in 1,103 high-risk women.
Eleanor L Cheung, Ashley D Olson, Tina M Yu, Pamela Z Han, Mary S Beattie. Cancer Epidemiol Biomarkers Prev 2010
55
20

Association of Attending Surgeon With Variation in the Receipt of Genetic Testing After Diagnosis of Breast Cancer.
Steven J Katz, Irina Bondarenko, Kevin C Ward, Ann S Hamilton, Monica Morrow, Allison W Kurian, Timothy P Hofer. JAMA Surg 2018
14
20

Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative.
Jennifer L Caswell-Jin, Anjali D Zimmer, Will Stedden, Kerry E Kingham, Alicia Y Zhou, Allison W Kurian. J Natl Cancer Inst 2019
37
20

Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
Joanne Armstrong, Michele Toscano, Nancy Kotchko, Sue Friedman, Marc D Schwartz, Katherine S Virgo, Kristian Lynch, James E Andrews, Claudia X Aguado Loi, Joseph E Bauer,[...]. JAMA Oncol 2015
78
20

Gene patents and personalized cancer care: impact of the Myriad case on clinical oncology.
Kenneth Offit, Angela Bradbury, Courtney Storm, Jon F Merz, Kevin E Noonan, Rebecca Spence. J Clin Oncol 2013
34
20

Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups.
Esther M John, Alexander Miron, Gail Gong, Amanda I Phipps, Anna Felberg, Frederick P Li, Dee W West, Alice S Whittemore. JAMA 2007
219
20

BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer.
Michael J Hall, Julia E Reid, Lynn A Burbidge, Dmitry Pruss, Amie M Deffenbaugh, Cynthia Frye, Richard J Wenstrup, Brian E Ward, Thomas A Scholl, Walter W Noll. Cancer 2009
223
20


Gaps in Receipt of Clinically Indicated Genetic Counseling After Diagnosis of Breast Cancer.
Steven J Katz, Kevin C Ward, Ann S Hamilton, M Chandler Mcleod, Lauren P Wallner, Monica Morrow, Reshma Jagsi, Sarah T Hawley, Allison W Kurian. J Clin Oncol 2018
36
20

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015
296
20

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
20

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
20

Genetic Misdiagnoses and the Potential for Health Disparities.
Arjun K Manrai, Birgit H Funke, Heidi L Rehm, Morten S Olesen, Bradley A Maron, Peter Szolovits, David M Margulies, Joseph Loscalzo, Isaac S Kohane. N Engl J Med 2016
304
20

Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.
Douglas E Levy, Stacey D Byfield, Catherine B Comstock, Judy E Garber, Sapna Syngal, William H Crown, Alexandra E Shields. Genet Med 2011
152
20

What Black Women Know and Want to Know About Counseling and Testing for BRCA1/2.
Inez Adams, Juleen Christopher, Karen Patricia Williams, Vanessa B Sheppard. J Cancer Educ 2015
23
20

Delivery Of Cascade Screening For Hereditary Conditions: A Scoping Review Of The Literature.
Megan C Roberts, W David Dotson, Christopher S DeVore, Erica M Bednar, Deborah J Bowen, Theodore G Ganiats, Ridgely Fisk Green, Georgia M Hurst, Alisdair R Philp, Charité N Ricker,[...]. Health Aff (Millwood) 2018
49
20

The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.
Fred H Menko, Jacqueline A Ter Stege, Lizet E van der Kolk, Kiki N Jeanson, Winnie Schats, Daoud Ait Moha, Eveline M A Bleiker. Fam Cancer 2019
37
20

Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update.
James L Khatcheressian, Patricia Hurley, Elissa Bantug, Laura J Esserman, Eva Grunfeld, Francine Halberg, Alexander Hantel, N Lynn Henry, Hyman B Muss, Thomas J Smith,[...]. J Clin Oncol 2013
327
20

Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling.
Morgan Butrick, Scott Kelly, Beth N Peshkin, George Luta, Rachel Nusbaum, Gillian W Hooker, Kristi Graves, Lisa Feeley, Claudine Isaacs, Heiddis B Valdimarsdottir,[...]. Genet Med 2015
58
20

Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers.
Brian Drohan, Constance A Roche, James C Cusack, Kevin S Hughes. Ann Surg Oncol 2012
56
20

Concise handbook of familial cancer susceptibility syndromes - second edition.
Noralane M Lindor, Mary L McMaster, Carl J Lindor, Mark H Greene. J Natl Cancer Inst Monogr 2008
171
20

The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective.
Julie Dutil, Volha A Golubeva, Alba L Pacheco-Torres, Hector J Diaz-Zabala, Jaime L Matta, Alvaro N Monteiro. Breast Cancer Res Treat 2015
46
20

A comparison of cancer risk assessment and testing outcomes in patients from underserved vs. tertiary care settings.
Huma Q Rana, Sarah R Cochrane, Elaine Hiller, Ruth N Akindele, Callie M Nibecker, Ludmila A Svoboda, Angel M Cronin, Judy E Garber, Christopher S Lathan. J Community Genet 2018
8
25

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.
Mary B Daly, Robert Pilarski, Michael Berry, Saundra S Buys, Meagan Farmer, Susan Friedman, Judy E Garber, Noah D Kauff, Seema Khan, Catherine Klein,[...]. J Natl Compr Canc Netw 2017
287
20

Genetic predisposition syndromes and their management.
David M Euhus, Linda Robinson. Surg Clin North Am 2013
17
20

Genomic Disparities in Breast Cancer Among Latinas.
Filipa Lynce, Kristi D Graves, Lina Jandorf, Charite Ricker, Eida Castro, Laura Moreno, Bianca Augusto, Laura Fejerman, Susan T Vadaparampil. Cancer Control 2016
26
20

A large kindred with 17q-linked breast and ovarian cancer: genetic, phenotypic, and genealogical analysis.
D E Goldgar, P Fields, C M Lewis, T D Tran, L A Cannon-Albright, J H Ward, J Swensen, M H Skolnick. J Natl Cancer Inst 1994
79
10

Integrated analysis of germline and somatic variants in ovarian cancer.
Krishna L Kanchi, Kimberly J Johnson, Charles Lu, Michael D McLellan, Mark D M Leiserson, Michael C Wendl, Qunyuan Zhang, Daniel C Koboldt, Mingchao Xie, Cyriac Kandoth,[...]. Nat Commun 2014
174
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.